TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
APYX

Apyx Medical Inc

Healthcare · Medical Devices

2.60$ +2.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Apyx Medical Inc (APYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 61 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet APYX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
29 35 33 33 31 31 30 31 113 96 92 89 87 85 82 78 75 74 71 70 68 69 63 59 55 52 57 62 59 79 71 65 61 65 60 58 57 67 63 61
20 27 25 24 22 23 22 22 107 90 85 82 79 77 74 70 68 66 63 62 60 61 55 51 46 43 53 53 50 70 62 57 52 56 52 50 49 58 55 53
9.3 14 12 10 9.4 9.9 8.7 7.9 41 16 32 67 62 59 51 46 44 42 40 35 31 31 26 20 15 10 16 18 22 44 37 33 28 32 31 29 25 32 31 28
9.3 14 12 10 9.4 9.9 8.7 7.9 96 78 73 67 62 59 51 46 44 42 40 35 31 31 26 20 15 10 16 18 22 44 37 33 28 32 31 29 25 32 31 28
3.9 4.7 4.3 4.9 4.1 4.9 5.1 5.6 4.1 5.0 4.9 6.2 7.7 9.2 12 14 15 17 16 18 20 21 20 18 17 18 18 20 13 14 12 13 13 15 12 11 13 17 13 14
5.9 6.2 7.4 7.6 7.3 6.5 6.7 7.5 6.0 5.2 5.6 6.4 7.2 5.1 5.9 5.3 5.4 4.1 4.5 5.3 6.0 6.8 7.0 9.7 12 12 11 11 11 9.9 9.8 9.3 9.0 7.6 7.7 8.2 9.1 8.6 9.5 11
6.5 6.4 6.4 6.2 6.4 6.4 6.3 6.3 5.8 5.8 6.0 6.3 6.6 6.6 6.5 6.4 6.3 7.2 7.2 7.0 6.8 6.6 6.7 6.8 7.7 6.8 2.1 2.1 – – – – – – – – – – – –
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
1.8 1.7 1.7 1.7 1.7 1.7 1.7 1.7 0.0 0.0 0.0 0.2 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
8.5 8.9 8.4 9.0 8.2 9.0 8.6 9.1 22 7.8 7.7 8.3 10 13 12 11 11 10 11 12 13 15 13 13 13 14 21 26 26 52 50 50 50 51 50 51 51 52 50 50
4.2 5.3 4.9 5.6 4.8 6.0 5.7 6.2 22 7.7 7.5 7.9 9.0 12 11 9.6 9.6 9.2 9.7 11 12 13 12 11 11 12 19 19 10 13 11 11 9.6 11 9.5 11 11 12 9.4 9.4
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 – – – – 0.3 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.3 0.3 0.2 0.2 0.3 0.3 9.0 9.3 0.3 0.4 0.4 0.3 0.4 0.4 0.4 0.4 0.4 0.4 0.4 0.5
1.7 1.6 2.2 2.1 1.4 1.6 2.1 2.7 2.3 1.4 1.5 1.6 1.5 2.4 2.5 2.2 2.5 1.5 2.3 2.8 3.0 2.6 2.6 2.6 2.1 2.7 1.9 2.7 2.1 2.7 2.1 2.3 1.9 2.6 2.3 2.9 3.2 3.1 2.6 2.2
3.7 2.8 2.8 2.7 2.7 2.6 2.5 2.5 0.1 0.1 0.1 0.1 0.1 – – – – – – – – – – – – – – – 9.0 33 33 34 34 34 34 34 35 35 35 35
21 26 25 24 23 22 21 22 91 88 84 81 77 71 70 67 64 64 60 57 54 54 50 46 42 38 36 37 33 27 20 15 11 14 11 7.3 5.8 15 13 11
-23 -23 -25 -26 -28 -28 -29 -30 39 36 31 26 21 15 13 7.9 4.1 2.6 -2.3 -6.3 -11 -13 -18 -24 -30 -36 -39 -40 -45 -54 -62 -69 -73 -78 -82 -86 -88 -89 -91 -94
27 29 31 31 31 33 33 27 35 34 33 33 34 34 34 34 34 34 34 34 34 34 34 34 35 35 35 35 35 35 35 35 35 38 36 41 41 42 42 42

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?